Brendan Teehan
Chief Operating Officer, Acadia Pharmaceuticals.
Companies
- Pacira BioSciences, Inc.Chief Commercial Officer Jan 28, 2025 to now1
- Acadia PharmaceuticalsChief operating officer Nov 5, 2021 to Nov 19, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Pacira BioSciences, Inc. PCRX100,934 shares3$3.7M at $36.36Feb 11, 2026
- Acadia Pharmaceuticals ACAD62,105 shares4$1.2M at $19.61Nov 19, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 11, 2026Granted 51,714 shares of Pacira BioSciences, Inc.3
- Jan 30, 2026Shares withheld for tax 5,182 shares at $20.54 of Pacira BioSciences, Inc.5
- Dec 31, 2025Granted 402 shares at $10.76 of Pacira BioSciences, Inc.6
- Feb 1, 2025Granted 54,000 shares of Pacira BioSciences, Inc.7
- Nov 19, 2024Sold 10,329 shares at $16.81 of Acadia Pharmaceuticals4
- Nov 17, 2024Exercised options 9,913 shares of Acadia Pharmaceuticals4
- Nov 17, 2024Exercised options 9,913 shares of Acadia Pharmaceuticals4
- Aug 19, 2024Sold 9,534 shares at $15.28 of Acadia Pharmaceuticals8
- Aug 16, 2024Granted 13,629 shares of Acadia Pharmaceuticals8
- Aug 16, 2024Granted 5,024 shares of Acadia Pharmaceuticals8
- May 2, 2024Sold 3,477 shares at $16.94 of Acadia Pharmaceuticals9
- May 1, 2024Exercised options 6,814 shares of Acadia Pharmaceuticals9
- Apr 8, 2024Sold 2,568 shares at $17.87 of Acadia Pharmaceuticals10
- Apr 5, 2024Exercised options 5,024 shares of Acadia Pharmaceuticals10
- Mar 27, 2024Sold 5,140 shares at $17.90 of Acadia Pharmaceuticals11
- Mar 25, 2024Granted 10,048 shares of Acadia Pharmaceuticals11
- Feb 26, 2024Sold 624 shares at $24.67 of Acadia Pharmaceuticals12
- Feb 23, 2024Exercised options 1,107 shares of Acadia Pharmaceuticals12
- Jan 8, 2024Sold 731 shares at $29.96 of Acadia Pharmaceuticals13
- Jan 6, 2024Exercised options 1,287 shares of Acadia Pharmaceuticals13
- Nov 20, 2023Sold 4,960 shares at $22.64 of Acadia Pharmaceuticals14
- Nov 17, 2023Exercised options 4,956 shares of Acadia Pharmaceuticals14
- Nov 17, 2023Exercised options 4,956 shares of Acadia Pharmaceuticals14
- May 17, 2023Sold 14,869 shares at $22.50 of Acadia Pharmaceuticals15
- May 17, 2023Exercised options 14,869 shares of Acadia Pharmaceuticals15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 3, 2026
- 6SEC EDGARForm 4 filed Jan 6, 2026
- 7SEC EDGARForm 4 filed Feb 4, 2025
- 8SEC EDGARForm 4 filed Aug 20, 2024
- 9SEC EDGARForm 4 filed May 3, 2024
- 10SEC EDGARForm 4 filed Apr 9, 2024
- 11SEC EDGARForm 4 filed Mar 27, 2024
- 12SEC EDGARForm 4 filed Feb 27, 2024
- 13SEC EDGARForm 4 filed Jan 9, 2024
- 14SEC EDGARForm 4 filed Nov 21, 2023
- 15SEC EDGARForm 4 filed May 19, 2023